Aurinia Pharmaceuticals (AUPH) Competitor Comparison
We are evaluating the key criteria listed to compare Aurinia Pharmaceuticals (AUPH) against its competitors in the Biotechnology industry.
Market Capitalization
135 / 368Gross Profits
51 / 278Total Revenue
69 / 300EBITDA
182 / 337Free Cashflow
37 / 352Quick Ratio
183 / 357Earnings per Share
53 / 359Dividend yield
0 / 6Total Cash
98 / 358Performance 3 years
176 / 368Performance 5 years
175 / 368Performance 10 years
49 / 368Linearity 3 years
172 / 368Linearity 5 years
144 / 368Linearity 10 years
178 / 367Total Rank
197 / 368Dividend Rank
50 / 368Valuation Rank
88 / 368Piotroski Rank
104 / 368Muliplier Rank
282 / 368Market Capitalization - AUPH ranking 135 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.